NCT04840056Recruiting
Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis
Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis - Application of Artificial Intelligence in Histology and Clinical Data
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
The primary objectives of this study are: * To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG * To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1300 (estimated)
- First submitted
- 23 Mar 2021
- Start date
- Apr 2021
- Primary completion date
- Dec 2026
- Lead sponsor
- Chinese University of Hong Kong
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT04840056
What you commit to
- Study type: Observational
- Planned participants: 1300
- From Apr 2021 to the primary completion date, Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- none
Who the study is looking for
- Adults \>= 18 years of age
- Histologically proven atrophic gastritis or intestinal metaplasia (at antrum and/or body and/or angular of stomach)
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Prince of Wales Hospital Coordinator of this site? Confirm its status | Shatin | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.